ESC 2021: Major Hypertension Trial Supports Tight BP Control with Data from Older Adults
Aggressive control of systolic BP in adults aged 60 to 80 years significantly reduced CV risk, adding to evidence from the pivotal SPRINT trial in support of tight BP control.
ESC 2021: Finerenone Now Shows Promise in Less Severe Diabetic Kidney Disease
Finerenone, in patients with mild-to-moderate renal disease and T2D, reduced CV event risk by 13% and risk for a composite renal event by 23%, study authors reported at ESC 2021.
Why Not Talk About Bariatric Surgery: What makes patients and healthcare professionals hesitate?
Why wouldn't a person with severe obesity want to talk about bariatric surgery? Why wouldn't the patient's physician want to do it? The reasons for hesitation are many.
ESC 2021: EMPORER-Preserved: Empagliflozin Reduces Composite CV Endpoint in HFpEF
Empagliflozin in patients with HFpEF reduced by 21% the risk of cardiovascular death or heart failure hospitalization across all prespecified subgroups, including those with/without diabetes.
Immunization Action Coalition President and Flu Expert Dr Kelly Moore Explains Primary Care's "Tall Order"
IAC president Kelly Moore, MD, MPH, has a long history of fighting flu and promoting vaccination. She talks about the influenza/COVID season to come and using the best tools we have.
European Society of Cardiology Congress 2021: Primary Care Preview
The ESC Congress 2021, Aug 27-30, 2021, is here. For primary care, we highlight the "Hot Lines" clinical trial presentations where new data from novel trials will premier.
USPSTF Lowers Age to Begin Screening for Diabetes, Prediabetes
Citing data that show the incidence of type 2 diabetes increases at age 35 years, the Task Force now recommends the younger age to initiate screening vs the current age of 40 years.
Adult Vaccination Against Preventable Diseases Now Urgent, says NAIIS
Low rates of routine adult vaccination, reduced further during the 2020-21 pandemic months, threaten a surge in these conditions as the US reopens, says the National Adult and Influenza Immunization Summit.
Rivaroxaban: New Indication for Use in PAD Following Lower Extremity Revascularization
With the post-LER PAD indication, rivaroxaban becomes the only anticoagulant in 2 decades to demonstrate safety and efficacy in the high-risk population.
8 More Ways to Talk to the Vaccine-hesitant
Talking to the COVID-19 vaccine-hesitant folks in your circle can be difficult. These 8 slides offer some new and some tried and true tips on how to approach the topic
FDA Grants Insulin Lispro-aabc Label Expansion for use in Insulin Pumps
The novel prandial insulin formulation from Eli Lilly is now approved for administration via continuous subcutaneous insulin infusion with an insulin pump.
COVID-19: Even Short Hospitalizations Lead to Long COVID Symptoms, Financial Hardship
COVID-19 patients after just 5 days or less in the hospital report new or worsened symptoms, impaired daily function, and significant financial loss.
Empagliflozin FDA-approved for Heart Failure with Reduced Ejection Fraction
The new indication for empagliflozin is to reduce risk of CV death and hospitalization for heart failure in patients with HFrEF,
9 States, 2 Cities Requiring COVID-19 Vaccination for all Health Care Workers
Delta variant rising and vaccine immunity possibly on the wane are 2 reasons cited by state governors and city mayors for requiring full vaccination of health care personnel.
ACP: Ensure Adult Routine Vaccinations are Up to Date as Flu and COVID Meet Again
The American College of Physicians urges clinicians to make sure adult patients, especially the most vulnerable, are protected against preventable diseases as COVID spreads and flu is imminent.
COVID-19 Vaccine Boosters May be Recommended for Most Americans
Recommendation for a COVID-19 booster for vaccinated Americans could come by Wednesday; some experts say data are too sparse to support the move.
Nearly 1 in 6 Heart Failure Patients Delay or Avoid Care, Half Cite Financial Reasons
Delaying or forfeiting care for HF significantly increased future health care costs, a finding at odds, say study authors, with the inability to afford regular treatment.
Back to School: Parents, the Pandemic, and the COVID Vaccine
COVID-19 vaccination mandates are not popular with parents of school-aged children, but masks for unvaccinated students and teachers are. More on a new KFF survey.
The "Lorna Breen Act" in Short
Click through a short summary of the provisions of the Dr Lorna Breen Health Care Provider Protection Act.
Dr Lorna Breen Health Care Provider Protection Act Passed by Senate in Unanimous Vote
The first-of-its-kind legislation would authorize $35 million for programs aimed at practitioner mental health education and campaigns to support seeking help.
Update: FDA Authorizes mRNA Booster Shot for Immunosuppressed Individuals
Update: The FDA authorized a 3rd COVID-19 vaccine dose for the immunocompromised to combat emergence of more pathogenic SARS-CoV-2 strains.
Patients on the Vaccine Fence? Threat Reduction May Help, says Syracuse Clinical Psychologist
Your COVID-19-vaccinated patients and the ones "on the fence" share a fear, but of different unknowns. Reduce the threat for the fence sitters, says Afton Kapuscincki, PhD.
Vaccine Hesitancy Often is Synonymous with Vaccine Confusion: Perspectives from Primary Care
The COVID-19 vaccine hesitancy echoed to this PCP from his multiethnic community is rooted in confusion. He talks about creating clarity, here.
Loneliness in Aging Adults Associated with High-risk Medication Use
Older adults who report being "highly lonely" are up to 2.5 times more likely to use opioid analgesics, sedatives, and anxiolytics.
Interview: The Vaccine-hesitant Patient Needs to Hear "Yes" from Primary Care
COVID-19 vaccine information that is culturally sensitive, clear, and concise may help reduce patient hesitation, but the PCP can shift a “maybe” to “yes.”
Overweight, Obesity Overlooked in Secondary CHD Prevention, Study Finds
Patients with overweight and obesity rarely received guidance on weight management after hospitalization for a coronary event, authors report.
COVID-19 Vaccine Blame Game is a Poor Strategy, Yale PCP Advises
Patients unvaccinated against COVID-19 don't need blame; they may need more of your time, though, says this primary care physician.
Framingham Heart Study in the New Millennium: Deeper Dives into CVD Risk
As FHS continues, advanced technology leads to discovery of genetic CVD risk; imaging studies refine risk assessment; gamification enters FHS research; and a 2019 grant ensures the future.
The Framingham Heart Study: Research to Clinical Practice Timeline
Findings from the Framingham Heart Study since its 1948 beginning have led to identification of and treatment for dozens of risk factors for cardiovascular disease. Which ones?
Patients with Severe OSA at Two-fold Higher Risk for Sudden Death, New Study Shows
Results of a new systematic review and meta-analysis by researchers at Penn State College of Medicine underscore needs for patient education and additional research on prevention.
